1. Home
  2. AIMD vs HIND Comparison

AIMD vs HIND Comparison

Compare AIMD & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ainos Inc.

AIMD

Ainos Inc.

SELL

Current Price

$1.24

Market Cap

10.6M

Sector

Health Care

ML Signal

SELL

Logo Vyome Holdings Inc.

HIND

Vyome Holdings Inc.

SELL

Current Price

$1.24

Market Cap

11.1M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
AIMD
HIND
Founded
1984
2017
Country
United States
United States
Employees
N/A
2
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
11.1M
IPO Year
2008
2016

Fundamental Metrics

Financial Performance
Metric
AIMD
HIND
Price
$1.24
$1.24
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $8.83
AVG Volume (30 Days)
★ 4.0M
11.3K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 64.86
EPS
N/A
★ N/A
Revenue
$124,157.00
★ $319,714.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$145.24
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 498.95
24.43
52 Week Low
$0.43
$1.45
52 Week High
$3.88
$5.88

Technical Indicators

Market Signals
Indicator
AIMD
HIND
Relative Strength Index (RSI) 60.79 18.42
Support Level $0.50 N/A
Resistance Level $1.75 $2.31
Average True Range (ATR) 0.30 0.10
MACD 0.08 -0.02
Stochastic Oscillator 51.47 4.58

Price Performance

Historical Comparison
AIMD
HIND

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

About HIND Vyome Holdings Inc.

Vyome Holdings Inc is a clinical-stage specialty pharmaceutical company working to treat immune-inflammatory and rare diseases of unmet need with next-generation therapeutic solutions. Its product candidates are: VT-1953, a topical gel that is being developed to treat signs and symptoms of malignant fungating wounds in cancer; VT-1908, a repurposed immune modulator to treat steroid-sparing anterior uveitis; and VB1953, which is being developed to treat moderate to severe acne. Vyome has also commercialized two novel reformulated topical anti-fungal products based on the technology platform of Molecular Replacement Therapeutics (MRT) in India: a dandruff lotion and shampoo. It operates in two segments: pharmaceutical products, which generate the maximum revenue, and biotechnology.

Share on Social Networks: